Summary

The probiotic supplements market is projected to expand from USD 10.60 billion in 2026 to USD 16.69 billion by 2031, at a high CAGR of 9.5%. Consumer awareness of digestive health, microbiome balance, immune support, and preventive healthcare consumption is driving market growth. Increasing demand for functional nutrition products and a strong shift towards science-based dietary supplements are contributing to this growth. There is an increased emphasis on developing novel probiotic formulas across all format types, including capsules, gummies & chewable, powders, tablets, and liquids to optimize convenience, stability and targeted health claims. Likewise, a boost to microbiome investment, strain-specific formulations, and clinically validated probiotic ingredients is further driving product innovation in this space. Companies are also broadening their product ranges to support multiple applications such as gastrointestinal health, immune health, women‘s health, oral health, metabolic health and pediatric health. Challenges in this market include regulatory nuances, such as stipulations on health claims, concerns about the stability of live organisms, and the high costs related to clinical trials and strain development. However, the increasing trend towards customized nutrition, the growing use of electronic channels, and the demand for functionally driven wellness products present significant growth opportunities for probiotic supplement manufacturers worldwide. “By product form, gummies & chewables are expected to be the fastest-growing segment during the forecast period.” Gummies and chewables are expected to be the fastest-growing product form segment in the probiotic supplements market during the forecast period. The market for probiotic gummies and chewables has been experiencing significant growth due to rising consumer demand for easy-to-eat, flavored supplement forms. This category is especially favored by children and younger populations. Recently, many companies have been developing probiotic gummy formulas with or without added vitamins and mineral premixes and prebiotics to support structure/function health claims such as digestive and immune system support. These formulas offer benefits such as improved mouthfeel, portability, and better compliance compared with traditional supplement forms. Capsules currently have the largest market share among all functional food/capsule products in the probiotic supplements market. This is because capsules are highly stable, provide accurate dosing, have a longer shelf life, and are easy for most adult consumers to take. Successfully delivering multiple probiotic strains in a single dosage form is also an additional benefit of capsules, and hence their applicability across all channels of distribution, such as pharmacies, drugstores, and healthcare channels, among others. “By health application, immunity support is expected to be the fastest-growing segment during the forecast period.” Immunity support is expected to be the fastest-growing health application segment in the probiotic supplements market during the forecast period. Rising consumer awareness of immune health, preventive healthcare, and wellness is a major factor fueling the acceptance of probiotic supplements designed to support immune health. More manufacturers are now creating specialized probiotic formulations with clinically validated strains of bacteria and yeast to help restore the balance of the gut microbiome and achieve a stronger immune response. Growing consumer knowledge of the impact of gut health on the immune system is also driving an increased demand for probiotic supplements targeted at immunity. Digestive health currently accounts for the largest share of the probiotic supplement market, driven by ever-increasing consumer awareness of digestive health, gut flora balance, and digestive support. Probiotic supplements are most commonly used to enhance digestion, intestinal health, and healthy gut flora across consumers of all age groups. “By end user, the children segment is expected to witness the fastest growth during the forecast period.” Children are anticipated to be the fastest-growing end-user segment in the probiotic supplements market during the forecast period. Rising parental awareness about children‘s gut health, immunity building, and digestive health is boosting the consumption of probiotic supplements among children. Manufacturers are now leveraging more pleasant taste profiles and more convenient administration forms (such as gummies, powders, chewables, and liquid drops) of child-friendly probiotics in the form of probiotic products. Rising awareness of preventive pediatrics, as well as other microbiome-centric nutrition solutions, has accelerated segment growth. The application ‘adults’ now captures the largest market share in the probiotic supplements market on account of high consumption of dietary supplements targeted at digestive health, immune system boosting, metabolic health and general preventive healthcare. Increasing health consciousness and growing use of daily wellness supplements by working population segments are driving the segment growth. “Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period.” Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period, owing to increasing consumer awareness regarding digestive wellness, immunity support, and preventive healthcare across the region. Rising disposable incomes, expanding middle-class population, rapid urbanization, and changing dietary habits are significantly contributing to the growing adoption of probiotic supplements in countries such as China, India, Japan, South Korea, and Australia. Growing consumer inclination toward healthy lifestyles, leading to enhanced adoption of probiotic capsules, gummies, powders, chewable, and liquid formulae, is significantly contributing to the expansion of the Asia Pacific market. Increasing adoption of functional foods and dietary supplements, wider retail availability, and growing penetration of e-commerce sites are other factors adding to the overall industry growth. In addition, companies are investing heavily in new product development, local formulations and broadening of distribution channels to increase their regional penetration. Additionally, rising emphasis on preventive care, pediatrics, women ‘s health and customized health solutions is anticipated to support healthy growth in the market over the forecast period. “By distribution channel, the E-commerce segment is expected to witness the fastest growth during the forecast period.” E-commerce is expected to be the fastest-growing distribution channel segment of the probiotic supplements market during the forecast period. The rise in product digitization, the surge in online purchasing of health products, and consumers' inclination toward ease of shopping are supporting the rapid growth of online sales of probiotic supplements. Consumers have more choices of products, subscription purchase options, product comparisons, customer reviews, and even 24/7 access to the most premium and limited-edition probiotic products through online platforms. Producers are increasingly using direct-to-consumer approaches and digital marketing campaigns to boost their success in online sales. Pharmacies and drugstores have the largest market share in the probiotic supplements market due to high consumer trust, product recommendations, and the wide availability of probiotics positioned for clinical use. Customers continue to report buying health-related probiotics at the pharmacy, and this behavior is supported by the credibility and reliability of these retailers. “By ingredient, the Saccharomyces boulardii segment is expected to witness the fastest growth during the forecast period.” Saccharomyces boulardii is expected to be the fastest-growing ingredient segment during the forecast period across the probiotic supplements market. Because there is more scientific research supporting the efficacy of Saccharomyces boulardii in managing digestive and gastrointestinal health and antibiotic-associated digestive disorders, the demand for Saccharomyces boulardii-based probiotic supplements is on the increase. As a result of its stability, survivability and compatibility with a wide variety of supplement formats, Saccharomyces boulardii is being integrated into targeted digestive health and immunity support products by an increasing number of manufacturers. Segments are further expanding as consumers demand higher levels of accuracy and strength associated with specific probiotic strains that offer proven benefits according to clinical studies. Lactobacilli represent the dominant segment of the probiotic supplements market currently. This is due to their presence in the largest number of applications, including digestive health, immune health, women ‘s health and general wellness. Moreover, strains of lactobacilli are the most utilized in probiotic supplement formulations because of the widespread clinical support, high awareness, and applications in capsule, powder, gummy and liquid formats. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Probiotic supplements market. ・ By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45% ・ By Designation: CXOs – 25%, Managers – 35%, Others – 40% ・ By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, South America – 10%, and Rest of the World –5% Prominent companies in the market include Nestlé S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc., Biogaia (Sweden), and others. Research Coverage This research report categorizes the probiotic supplements market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application (Digestive Health, Immunity Support, Women's Health, Metabolic Health, Gut Health, Oral Health, and Other Health Applications), End User (Infant, Children, Adults, and Geriatric Population), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, E-commerce, and Other Distribution Channel), Ingredient (Bacteria (Lactobacilli, Bifidobacterium, Bacillus, Streptococcus Thermophilus) and Yeast (Saccharomyces Boulardii, Other Yeasts)), and Region (North America, Europe, Asia Pacific, South America, and Rest of the World). The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the Probiotic supplements industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Probiotic supplements market. This report provides a competitive analysis of emerging startups in the Probiotic supplements market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others. Reasons to Buy This Report The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Probiotic supplements and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: ・ Analysis of key drivers (Increasing consumer awareness regarding digestive health and immunity support for Probiotic supplements), restraints (Stability and shelf-life challenges associated with probiotic strains), opportunities (Expansion of personalized nutrition and targeted probiotic formulations), and challenges (Managing formulation complexity across multiple probiotic strains), influencing the growth of the probiotic supplements market ・ Product Development/Innovation: Detailed insights into research & development activities and new product launches in the Probiotic supplements market ・ Market Development: Comprehensive information about the lucrative market analysis of probiotic supplements across varied regions ・ Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Probiotic supplements market ・ Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Nestlé S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc. (UK), BioGaia (Sweden), Metagenics, Inc. (UK), OptiBiotix Health Plc (UK), Nature's Way Products, LLC (UK), Optibac Probiotics Ltd. (UK), AB-BIOTICS S.A. (Spain), Lifeway Foods, Inc. (UK), and other players in the probiotic supplements market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE AND SEGMENTATION 35
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 35
1.3.2 INCLUSIONS AND EXCLUSIONS 36
1.4 YEARS CONSIDERED 37
1.5 CURRENCY CONSIDERED 37
1.6 STAKEHOLDERS 38
2 EXECUTIVE SUMMARY 39
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 39
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 40
2.3 DISRUPTIVE TRENDS IN PROBIOTIC SUPPLEMENTS MARKET 41
2.4 HIGH-GROWTH SEGMENTS 42
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 43
3 PREMIUM INSIGHTS 45
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET 45
3.2 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM AND REGION 46
3.3 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT 46
3.4 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 47
3.5 PROBIOTIC SUPPLEMENTS MARKET, BY END USER 47
3.6 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION 48
3.7 PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY 48
4 MARKET OVERVIEW 49
4.1 INTRODUCTION 49
4.2 MARKET DYNAMICS 50
4.2.1 DRIVERS 51
4.2.1.1 Rising prevalence of digestive health disorders and gastrointestinal diseases 51
4.2.1.2 Growing consumer focus on preventive healthcare and wellness 52
4.2.1.3 Increasing scientific evidence supporting microbiome health benefits 52
4.2.2 RESTRAINTS 53
4.2.2.1 Regulatory complexities and health claim restrictions 53
4.2.2.2 Stability and shelf-life challenges of live probiotic organisms 54
4.2.3 OPPORTUNITIES 55
4.2.3.1 Expansion of personalized nutrition and microbiome-based supplementation 55
4.2.3.2 Innovation in delivery formats like gummies, chewables, and stick packs 56
4.2.4 CHALLENGES 57
4.2.4.1 Scientific debate and inconsistent clinical outcomes across strains 57
4.2.4.2 Regulatory restrictions on health claims and marketing communications 57
4.3 UNMET NEEDS AND WHITE SPACES 57
4.3.1 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET 58
4.3.1.1 Improved probiotic survivability and delivery efficiency 58
4.3.1.2 Cost-effective and scalable solutions for emerging markets 58
4.3.1.3 Stronger clinical validation and healthcare adoption 59
4.3.2 WHITE SPACE OPPORTUNITIES 59
4.3.2.1 Women's microbiome and hormonal health solutions 59
4.3.2.2 Postbiotic and next-generation microbiome products 59
4.3.2.3 Probiotic supplements for mental wellness and the gut-brain axis 59
4.3.2.4 Personalized digital microbiome ecosystems 59
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60
4.4.1 INTERCONNECTED MARKETS 60
4.4.2 CROSS-SECTOR OPPORTUNITIES 60
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
4.5.1 KEY MOVES AND STRATEGIC FOCUS 61
5 INDUSTRY TRENDS 62
5.1 PORTER’S FIVE FORCES ANALYSIS 62
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 63
5.1.2 BARGAINING POWER OF SUPPLIERS 63
5.1.3 BARGAINING POWER OF BUYERS 63
5.1.4 THREAT OF SUBSTITUTES 64
5.1.5 THREAT OF NEW ENTRANTS 64
5.2 MACROECONOMICS OUTLOOK 64
5.2.1 RISING GLOBAL POPULATION AND INCREASING DEMAND FOR PREVENTIVE HEALTHCARE 64
5.2.2 EXPANSION OF E-COMMERCE AND DIGITAL HEALTH ECOSYSTEMS 66
5.3 SUPPLY CHAIN ANALYSIS 67
5.3.1 UPSTREAM (RAW MATERIALS & INGREDIENT SUPPLIERS) 67
5.3.2 INGREDIENT PROCESSING & MANUFACTURING 68
5.3.3 SUPPLEMENT MANUFACTURING & FORMULATION 68
5.3.4 DISTRIBUTION & COMMERCIALIZATION 68
5.3.5 END USERS 68
5.3.6 SUPPORTING ECOSYSTEM 68
 
5.4 ECOSYSTEM ANALYSIS 69
5.5 PRICING ANALYSIS 70
5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT FORM 71
5.5.2 AVERAGE SELLING PRICE, BY REGION 71
5.6 TRADE ANALYSIS 72
5.6.1 IMPORT SCENARIO (HS CODE 300490) 72
5.6.2 EXPORT SCENARIO (HS CODE 300490) 73
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 74
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
5.9 INVESTMENT AND FUNDING SCENARIO 75
5.10 CASE STUDY ANALYSIS 76
5.10.1 PENDULUM THERAPEUTICS INTRODUCED GLUCOSE CONTROL PROBIOTIC FOR METABOLIC HEALTH 76
5.10.2 NESTLÉ HEALTH SCIENCE LAUNCHED PERSONALIZED NUTRITION PLATFORM TO SUPPORT GUT HEALTH 76
5.11 IMPACT OF 2025 US TARIFF – PROBIOTIC SUPPLEMENTS MARKET 76
5.11.1 INTRODUCTION 76
5.11.2 KEY TARIFF RATES 77
5.11.3 PRICE IMPACT ANALYSIS 78
5.11.4 IMPACT ON COUNTRIES/REGIONS 78
5.11.4.1 US 78
5.11.4.2 Europe 78
5.11.4.3 Asia Pacific 78
5.11.5 IMPACT ON END-USE INDUSTRIES 79
5.11.6 US TARIFF UPDATE (2026) AND LEGAL DEVELOPMENTS 79
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 80
6.1 KEY TECHNOLOGIES 80
6.1.1 MICROENCAPSULATION 80
6.1.2 GENOMIC & METAGENOMIC SEQUENCING 80
6.1.3 LYOPHILIZATION (FREEZE-DRYING) 80
6.2 COMPLEMENTARY TECHNOLOGIES 81
6.2.1 AI-DRIVEN PERSONALIZATION & DIGITAL HEALTH INTEGRATION 81
6.2.2 COLD-CHAIN INNOVATION & ADVANCED STABILITY LOGISTICS 81
6.3 ADJACENT TECHNOLOGIES 81
6.3.1 PRECISION FERMENTATION 81
6.3.2 SYNTHETIC BIOLOGY & STRAIN ENGINEERING 81
6.4 TECHNOLOGY ROADMAP 82
6.5 PATENT ANALYSIS 82
6.5.1 INTRODUCTION 82
6.5.2 LIST OF MAJOR PATENTS, MARCH 2020–DECEMBER 2024 84
6.6 FUTURE APPLICATIONS 85
6.6.1 PERSONALIZED MICROBIOME-BASED NUTRITION 85
6.6.2 MENTAL WELLNESS AND GUT-BRAIN HEALTH 86
6.6.3 WOMEN'S HEALTH SOLUTIONS 86
6.6.4 LIVE BIOTHERAPEUTIC PRODUCTS (LBPS) 86
6.6.5 AI-ENABLED PERSONALIZED PROBIOTIC ECOSYSTEMS 87
6.7 IMPACT OF AI/GEN AI ON PROBIOTIC SUPPLEMENTS INDUSTRY 87
6.7.1 TOP USE CASES AND MARKET POTENTIALS 87
6.7.2 BEST PRACTICES IN PROBIOTIC SUPPLEMENTS INDUSTRY 88
6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PROBIOTIC SUPPLEMENTS MARKET 88
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROBIOTIC SUPPLEMENTS MARKET 90
6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 90
6.8.1 DSM-FIRMENICH: AI4B.IO FOR BIOSCIENCE INNOVATION 90
6.8.2 NESTLÉ HEALTH SCIENCE: PERSONALIZED NUTRITION PLATFORM 91
6.8.3 VIOME: AI-POWERED MICROBIOME PERSONALIZATION 91
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 92
7.1 REGIONAL REGULATIONS AND COMPLIANCE 92
7.1.1 REGULATORY FRAMEWORK 92
7.1.1.1 North America 92
7.1.1.1.1 US 92
7.1.1.1.2 Canada 94
7.1.1.1.3 Mexico 95
7.1.1.2 Europe 96
7.1.1.2.1 Germany 96
7.1.1.2.2 UK 98
7.1.1.2.3 France 99
7.1.1.2.4 Italy 100
7.1.1.2.5 Spain 101
7.1.1.2.6 Rest of Europe 103
7.1.1.3 Asia Pacific 103
7.1.1.3.1 China 103
7.1.1.3.2 India 104
7.1.1.3.3 Japan 106
7.1.1.3.4 South Korea 107
7.1.1.3.5 Australia & New Zealand 108
7.1.1.3.6 Rest of Asia Pacific 109
7.1.1.4 South America 110
7.1.1.4.1 Brazil 110
7.1.1.4.2 Rest of South America 111
7.1.1.5 RoW 112
7.1.1.5.1 Middle East Region 112
7.1.1.5.2 Africa Region 112
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
7.1.3 INDUSTRY STANDARDS 120
7.1.4 DOCUMENTATION REQUIREMENTS 123
7.1.5 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 126
7.2 SUSTAINABILITY INITIATIVES 127
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127
7.3.1 CERTIFICATIONS, LABELING, ECO-STANDARDS 128
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 129
8.1 DECISION-MAKING PROCESS 129
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 130
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 130
8.2.2 BUYING CRITERIA 131
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 133
8.5 MARKET PROFITABILITY 134
8.5.1 REVENUE POTENTIAL 135
8.5.2 COST DYNAMICS 135
8.5.3 MARGIN OPPORTUNITIES, BY PRODUCT FORMAT 136
9 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM 137
9.1 INTRODUCTION 138
9.2 TABLETS & SOFTGELS 140
9.2.1 CONVENIENT DOSAGE FORMAT SUPPORTING DEMAND FOR PROBIOTIC TABLET SUPPLEMENTS 140
9.3 CAPSULES 141
9.3.1 HIGH STABILITY AND STRAIN PROTECTION DRIVING DEMAND FOR PROBIOTIC CAPSULES 141
9.4 POWDER 142
9.4.1 FLEXIBLE DOSING AND PEDIATRIC APPLICATIONS DRIVING DEMAND FOR PROBIOTIC POWDER FORMULATIONS 142
9.5 GUMMIES & CHEWABLES 143
9.5.1 INCREASING FOCUS ON PALATABLE AND CONSUMER-FRIENDLY SUPPLEMENTS DRIVING GUMMY PROBIOTIC DEMAND 143
9.6 LIQUID 144
9.6.1 RAPID ABSORPTION AND PEDIATRIC SUITABILITY SUPPORTING DEMAND FOR LIQUID PROBIOTIC FORMULATIONS 144
9.7 OTHER PRODUCT FORMS 145
 
10 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 147
10.1 INTRODUCTION 148
10.2 HYPERMARKETS/SUPERMARKETS 149
10.2.1 HIGH PRODUCT VISIBILITY AND CONSUMER ACCESSIBILITY SUPPORTING PROBIOTIC SALES THROUGH MODERN RETAIL CHANNELS 149
10.3 PHARMACIES/DRUGSTORES 150
10.3.1 STRONG CONSUMER TRUST AND HEALTHCARE-ORIENTED PURCHASING DRIVING PROBIOTIC SALES THROUGH PHARMACIES 150
10.4 SPECIALTY STORES 151
10.4.1 RISING POPULARITY OF PREMIUM AND TARGETED NUTRITION PRODUCTS DRIVING GROWTH OF SPECIALTY HEALTH STORES 151
10.5 E-COMMERCE 152
10.5.1 RAPID DIGITALIZATION AND ONLINE WELLNESS PURCHASING FUELING EXPANSION OF E-COMMERCE CHANNELS 152
10.6 OTHER DISTRIBUTION CHANNELS 154
11 PROBIOTIC SUPPLEMENTS MARKET, BY END USER 155
11.1 INTRODUCTION 156
11.2 INFANTS 157
11.2.1 INCREASING FOCUS ON EARLY-LIFE MICROBIOME DEVELOPMENT DRIVING DEMAND FOR INFANT PROBIOTIC SUPPLEMENTS 157
11.3 CHILDREN 158
11.3.1 RISING PARENTAL AWARENESS REGARDING PEDIATRIC IMMUNITY AND DIGESTIVE WELLNESS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS 158
11.4 ADULTS 159
11.4.1 INCREASING PREVALENCE OF LIFESTYLE-RELATED HEALTH CONDITIONS SUPPORTING ADULT PROBIOTIC CONSUMPTION 159
11.5 GERIATRIC POPULATION 160
11.5.1 GROWING AGING POPULATION AND DIGESTIVE HEALTH CONCERNS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS AMONG GERIATRIC CONSUMERS 160
12 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION 162
12.1 INTRODUCTION 163
12.2 DIGESTIVE HEALTH 164
12.2.1 GROWING PREVALENCE OF GASTROINTESTINAL DISORDERS SUPPORTING DEMAND FOR DIGESTIVE HEALTH PROBIOTIC SUPPLEMENTS 164
12.3 IMMUNITY SUPPORT 165
12.3.1 INCREASING FOCUS ON IMMUNE RESILIENCE DRIVING ADOPTION OF IMMUNITY SUPPORT PROBIOTIC SUPPLEMENTS 165
12.4 WOMEN’S HEALTH 167
12.4.1 RISING FOCUS ON VAGINAL, URINARY, AND HORMONAL WELLNESS DRIVING DEMAND FOR WOMEN’S HEALTH PROBIOTIC SUPPLEMENTS 167
12.5 METABOLIC HEALTH 168
12.5.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISORDERS SUPPORTING DEMAND FOR METABOLIC HEALTH PROBIOTIC SUPPLEMENTS 168
12.6 ORAL HEALTH 169
12.6.1 RISING PREVALENCE OF DENTAL CARIES, GINGIVITIS, AND ORAL MICROBIOME IMBALANCE DRIVING DEMAND FOR ORAL HEALTH PROBIOTIC SUPPLEMENTS 169
12.7 OTHER HEALTH APPLICATIONS 170
13 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT 172
13.1 INTRODUCTION 173
13.2 BACTERIA 174
13.2.1 STRONG CLINICAL VALIDATION AND WIDESPREAD DIGESTIVE HEALTH APPLICATIONS SUPPORTING BACTERIAL PROBIOTIC DOMINANCE 174
13.2.2 LACTOBACILLI 175
13.2.3 BIFIDOBACTERIUM 175
13.2.4 BACILLUS 176
13.2.5 STREPTOCOCCUS THERMOPHILUS 176
13.3 YEAST 176
13.3.1 INCREASING UTILIZATION OF STABLE MICROORGANISM STRAINS SUPPORTING YEAST-BASED PROBIOTICS DEMAND 176
13.3.2 SACCHAROMYCES BOULARDII 177
13.3.3 OTHER YEASTS 178
14 PROBIOTIC SUPPLEMENTS MARKET, BY REGION 179
14.1 INTRODUCTION 180
14.2 NORTH AMERICA 182
14.2.1 US 187
14.2.1.1 Strong microbiome health awareness and high functional supplement adoption to drive market 187
14.2.2 CANADA 189
14.2.2.1 Growing functional food consumption and strong regulatory oversight to support market growth 189
14.2.3 MEXICO 191
14.2.3.1 Rising health awareness and expanding functional nutrition demand to support market development 191
14.3 EUROPE 193
14.3.1 GERMANY 199
14.3.1.1 Strong dietary supplement industry and increasing preventive healthcare awareness to support market growth 199
14.3.2 UK 201
14.3.2.1 Expanding e-commerce healthcare retail and growing gut health awareness to drive market 201
14.3.3 FRANCE 202
14.3.3.1 Strong preventive healthcare culture and scientific engagement to support market expansion 202
14.3.4 SPAIN 204
14.3.4.1 Growing consumer awareness and increasing digestive health focus to support market growth 204
14.3.5 ITALY 206
14.3.5.1 High consumer familiarity with probiotics and strong pharmacy distribution channels to support market expansion 206
14.3.6 REST OF EUROPE 207
14.4 ASIA PACIFIC 209
14.4.1 CHINA 215
14.4.1.1 Growing digestive health awareness and expanding nutraceutical industry to drive market 215
14.4.2 JAPAN 217
14.4.2.1 High consumer awareness regarding gut health and strong healthy aging demand to support market expansion 217
14.4.3 SOUTH KOREA 219
14.4.3.1 Strong functional nutrition culture and expanding online supplement sales to support market growth 219
14.4.4 INDIA 221
14.4.4.1 Rising digestive health concerns and expanding nutraceutical industry to drive market 221
14.4.5 AUSTRALIA & NEW ZEALAND 223
14.4.5.1 Strong preventive healthcare culture and high supplement consumption to support market expansion 223
14.4.6 REST OF ASIA PACIFIC 224
14.5 SOUTH AMERICA 226
14.5.1 BRAZIL 231
14.5.1.1 Large consumer base, expanding dietary supplement industry, and rising gut health awareness to support market growth 231
14.5.2 ARGENTINA 233
14.5.2.1 Increasing healthcare awareness and growing preventive nutrition adoption to support market expansion 233
14.5.3 REST OF SOUTH AMERICA 235
14.6 REST OF THE WORLD 237
14.6.1 MIDDLE EAST 242
14.6.1.1 High healthcare expenditure, rising lifestyle-related diseases, and growing wellness consumption to drive market 242
14.6.2 AFRICA 244
14.6.2.1 Rising healthcare awareness, growing digestive health concerns, and expanding pharmacy retail infrastructure to drive market 244
15 COMPETITIVE LANDSCAPE 246
15.1 OVERVIEW 246
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2026 246
15.3 REVENUE ANALYSIS, 2023–2025 248
15.4 MARKET SHARE ANALYSIS, 2025 250
15.5 BRAND COMPARISON 253
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 255
15.6.1 STARS 255
15.6.2 EMERGING LEADERS 255
15.6.3 PERVASIVE PLAYERS 255
15.6.4 PARTICIPANTS 256
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 257
15.6.5.1 Company footprint 257
15.6.5.2 Region footprint 258
15.6.5.3 Health application footprint 259
15.6.5.4 Product form footprint 260
15.6.5.5 End user footprint 261
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 262
15.7.1 PROGRESSIVE COMPANIES 262
15.7.2 RESPONSIVE COMPANIES 262
15.7.3 DYNAMIC COMPANIES 262
15.7.4 STARTING BLOCKS 262
15.7.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025 264
15.7.5.1 Detailed list of key startups/SMEs 264
15.7.5.2 Competitive benchmarking of key startups/SMEs 265
15.8 COMPANY VALUATION AND FINANCIAL METRICS 266
15.8.1 COMPANY VALUATION 266
15.8.2 EV/EBITDA 266
15.9 COMPETITIVE SCENARIO 267
15.9.1 PRODUCT LAUNCHES 267
15.9.2 DEALS 269
15.9.3 EXPANSIONS 271
16 COMPANY PROFILES 272
16.1 KEY PLAYERS 272
16.1.1 NESTLÉ S.A. 272
16.1.1.1 Business overview 272
16.1.1.2 Products/Solutions/Services offered 273
16.1.1.3 Recent developments 274
16.1.1.3.1 Deals 274
16.1.1.4 MnM view 275
16.1.1.4.1 Right to win 275
16.1.1.4.2 Strategic choices 275
16.1.1.4.3 Weaknesses and competitive threats 275
16.1.2 YAKULT HONSHA CO., LTD. 276
16.1.2.1 Business overview 276
16.1.2.2 Products/Solutions/Services offered 277
16.1.2.3 Recent developments 278
16.1.2.3.1 Product launches 278
16.1.2.3.2 Deals 278
16.1.2.4 MnM view 279
16.1.2.4.1 Right to win 279
16.1.2.4.2 Strategic choices 279
16.1.2.4.3 Weaknesses and competitive threats 279
16.1.3 BIOGAIA 280
16.1.3.1 Business overview 280
16.1.3.2 Products/Solutions/Services offered 281
16.1.3.3 Recent developments 282
16.1.3.3.1 Product launches 282
16.1.3.3.2 Deals 282
16.1.3.4 MnM view 283
16.1.3.4.1 Right to win 283
16.1.3.4.2 Strategic choices 283
16.1.3.4.3 Weaknesses and competitive threats 283
16.1.4 KERRY GROUP PLC 284
16.1.4.1 Business overview 284
16.1.4.2 Products/Solutions/Services offered 285
16.1.4.3 Recent developments 286
16.1.4.3.1 Deals 286
16.1.4.4 MnM view 286
16.1.4.4.1 Right to win 286
16.1.4.4.2 Strategic choices 286
16.1.4.4.3 Weaknesses and competitive threats 286
16.1.5 AMWAY 287
16.1.5.1 Business overview 287
16.1.5.2 Products/Solutions/Services offered 288
16.1.5.3 Recent developments 289
16.1.5.3.1 Product launches 289
16.1.5.4 MnM view 289
16.1.5.4.1 Right to win 289
16.1.5.4.2 Strategic choices 289
16.1.5.4.3 Weaknesses and competitive threats 289
16.1.6 NATURE’S WAY 290
16.1.6.1 Business overview 290
16.1.6.2 Products/Solutions/Services offered 291
16.1.6.3 Recent developments 292
16.1.6.3.1 Expansions 292
16.1.6.4 MnM view 292
16.1.7 HERBALIFE LTD. 293
16.1.7.1 Business overview 293
16.1.7.2 Products/Solutions/Services offered 294
16.1.7.3 Recent developments 295
16.1.7.3.1 Deals 295
16.1.7.4 MnM view 295
16.1.8 MORINAGA MILK INDUSTRY CO., LTD. 296
16.1.8.1 Business overview 296
16.1.8.2 Products/Solutions/Services offered 297
16.1.8.3 Recent developments 298
16.1.8.3.1 Deals 298
16.1.8.4 MnM view 298
16.1.9 JARROW FORMULAS, INC. 299
16.1.9.1 Business overview 299
16.1.9.2 Products/Solutions/Services offered 300
16.1.9.3 Recent developments 300
16.1.9.3.1 Product launches 300
16.1.9.3.2 Deals 301
16.1.9.4 MnM view 301
16.1.10 SYMRISE AG 302
16.1.10.1 Business overview 302
16.1.10.2 Products/Solutions/Services offered 303
16.1.10.3 Recent developments 304
16.1.10.3.1 Product launches 304
16.1.10.4 MnM view 304
16.1.11 METAGENICS, INC. 305
16.1.11.1 Business overview 305
16.1.11.2 Products/Solutions/Services offered 305
16.1.11.3 Recent developments 306
16.1.11.3.1 Deals 306
16.1.11.4 MnM view 306
16.1.12 OPTIBIOTIX HEALTH PLC 307
16.1.12.1 Business overview 307
16.1.12.2 Products/Solutions/Services offered 308
16.1.12.3 Recent developments 308
16.1.12.4 MnM view 309
16.1.13 OPTIBAC PROBIOTICS LTD. 310
16.1.13.1 Business overview 310
16.1.13.2 Products/Solutions/Services offered 311
16.1.13.3 Recent developments 312
16.1.13.3.1 Product launches 312
16.1.13.4 MnM view 312
16.1.14 AB-BIOTICS S.A. 313
16.1.14.1 Business overview 313
16.1.14.2 Products/Solutions/Services offered 314
16.1.14.3 Recent developments 314
16.1.14.3.1 Deals 314
16.1.14.4 MnM view 315
16.1.15 LIFEWAY FOODS, INC. 316
16.1.15.1 Business overview 316
16.1.15.2 Products/Solutions/Services offered 317
16.1.15.3 Recent developments 318
16.1.15.4 MnM view 318
16.2 STARTUPS/SMES 319
16.2.1 SEED HEALTH, INC. 319
16.2.1.1 Business overview 319
16.2.1.2 Products/Solutions/Services offered 319
16.2.1.3 Recent developments 320
16.2.1.3.1 Product launches 320
16.2.1.4 MnM view 320
16.2.2 PENDULUM THERAPEUTICS 321
16.2.2.1 Business overview 321
16.2.2.2 Products/Solutions/Services offered 321
16.2.2.3 Recent developments 322
16.2.2.3.1 Product launches 322
16.2.2.3.2 Deals 322
16.2.2.4 MnM view 322
16.2.3 FLORE INC. 323
16.2.3.1 Business overview 323
16.2.3.2 Products/Solutions/Services offered 323
16.2.3.3 Recent developments 324
16.2.3.4 MnM view 324
16.2.4 CUSTOM PROBIOTICS INC. 325
16.2.4.1 Business overview 325
16.2.4.2 Products/Solutions/Services offered 325
16.2.4.3 Recent developments 326
16.2.4.4 MnM view 326
16.2.5 ORA ORGANIC 327
16.2.5.1 Business overview 327
16.2.5.2 Products/Solutions/Services offered 328
16.2.5.3 Recent developments 328
16.2.5.4 MnM view 328
16.2.6 LOVEBUG PROBIOTICS 329
16.2.7 BIOHM HEALTH 330
16.2.8 TONIIQ 331
16.2.9 FITBIOMICS 332
16.2.10 RESBIOTIC NUTRITION 332
17 RESEARCH METHODOLOGY 333
17.1 RESEARCH DATA 333
17.1.1 SECONDARY DATA 334
17.1.1.1 Key data from secondary sources 334
17.1.2 PRIMARY DATA 335
17.1.2.1 Key data from primary sources 335
17.1.2.2 Breakdown of primary profiles 336
17.1.2.3 Key insights from industry experts 336
17.2 MARKET SIZE ESTIMATION 337
17.2.1 SUPPLY SIDE 339
17.3 DATA TRIANGULATION 341
17.4 RESEARCH ASSUMPTIONS 342
17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 343
18 ADJACENT & RELATED MARKETS 344
18.1 INTRODUCTION 344
18.2 LIMITATIONS 344
18.3 NUTRACEUTICAL INGREDIENTS MARKET 344
18.3.1 MARKET DEFINITION 344
18.3.2 MARKET OVERVIEW 345
18.4 PROBIOTICS MARKET 346
18.4.1 MARKET DEFINITION 346
18.4.2 MARKET OVERVIEW 346
19 APPENDIX 348
19.1 DISCUSSION GUIDE 348
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 355
19.3 CUSTOMIZATION OPTIONS 357
19.4 RELATED REPORTS 357
19.5 AUTHOR DETAILS 358

ページTOPに戻る

List of Tables/Graphs

TABLE 1 USD EXCHANGE RATES, 2020–2024 38
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PROBIOTIC SUPPLEMENTS MARKET 63
TABLE 3 ROLES OF COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET ECOSYSTEM 70
TABLE 4 IMPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS,
BY KEY COUNTRY, 2025–2023 (KG) 72
TABLE 5 EXPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS,
BY KEY COUNTRY, 2025–2023 (KG) 73
TABLE 6 PROBIOTIC SUPPLEMENTS MARKET: LIST OF KEY CONFERENCES AND
EVENTS, 2026–2027 74
TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES 77
TABLE 8 TOP USE CASES AND MARKET POTENTIAL 87
TABLE 9 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 88
TABLE 10 PROBIOTIC SUPPLEMENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 88
TABLE 11 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 89
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 113
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 114
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 117
TABLE 15 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 118
TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119
TABLE 17 GLOBAL INDUSTRY STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET 121
TABLE 18 DOCUMENTATION REQUIREMENTS AND CLAIMS IN PROBIOTIC
SUPPLEMENTS MARKET 123
TABLE 19 CERTIFICATIONS, ACCREDITATION, AND ECO-STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET 128
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT 131
TABLE 21 KEY BUYING CRITERIA, BY PRODUCT FORMAT 132
TABLE 22 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET, BY END-USE APPLICATION 134
TABLE 23 COST DYNAMICS IN PROBIOTIC SUPPLEMENTS MARKET 135
TABLE 24 MARGIN OPPORTUNITIES IN PROBIOTIC SUPPLEMENTS MARKET,
BY PRODUCT FORMAT 136
TABLE 25 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 139
TABLE 26 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 139
TABLE 27 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (TONS) 139
TABLE 28 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (TONS) 140
TABLE 29 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 140
TABLE 30 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 141
TABLE 31 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 141
TABLE 32 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 142
TABLE 33 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 143
TABLE 34 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 143
TABLE 35 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 144
TABLE 36 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 144
TABLE 37 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 145
TABLE 38 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 145
TABLE 39 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 146
TABLE 40 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 146
TABLE 41 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 149
TABLE 42 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 149
TABLE 43 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 150
TABLE 44 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 150
TABLE 45 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 151
TABLE 46 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 151
TABLE 47 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 152
TABLE 48 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 152
TABLE 49 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 153
TABLE 50 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 153
TABLE 51 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 154
TABLE 52 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 154
TABLE 53 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022–2025 (USD MILLION) 157
TABLE 54 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026–2031 (USD MILLION) 157
TABLE 55 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 158
TABLE 56 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 158
TABLE 57 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 159
TABLE 58 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 159
TABLE 59 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 160
TABLE 60 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 160
TABLE 61 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 161
TABLE 62 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 161
TABLE 63 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION,
2022–2025 (USD MILLION) 164
TABLE 64 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION,
2026–2031 (USD MILLION) 164
TABLE 65 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 165
TABLE 66 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 165
TABLE 67 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 166
TABLE 68 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 166
TABLE 69 WOMEN’S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 167
TABLE 70 WOMEN’S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 168
TABLE 71 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 169
TABLE 72 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 169
TABLE 73 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 170
TABLE 74 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 170
TABLE 75 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2022–2025 (USD MILLION) 171
TABLE 76 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 171
TABLE 77 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION) 174
TABLE 78 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION) 174
TABLE 79 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 175
TABLE 80 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 175
TABLE 81 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 177
TABLE 82 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 177
TABLE 83 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022–2025 (USD MILLION) 181
TABLE 84 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 182
TABLE 85 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 182
TABLE 86 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 183
TABLE 87 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022–2025 (USD MILLION) 183
TABLE 88 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026–2031 (USD MILLION) 183
TABLE 89 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 184
TABLE 90 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 184
TABLE 91 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (TONS) 184
TABLE 92 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (TONS) 185
TABLE 93 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 185
TABLE 94 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 185
TABLE 95 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2022–2025 (USD MILLION) 186
TABLE 96 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026–2031 (USD MILLION) 186
TABLE 97 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2022–2025 (USD MILLION) 186
TABLE 98 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2026–2031 (USD MILLION) 186
TABLE 99 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 187
TABLE 100 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 188
TABLE 101 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 188
TABLE 102 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 188
TABLE 103 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 189
TABLE 104 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 190
TABLE 105 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 190
TABLE 106 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 190
TABLE 107 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 191
TABLE 108 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 192
TABLE 109 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 192
TABLE 110 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 192
TABLE 111 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 194
TABLE 112 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 195
TABLE 113 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION,
2022–2025 (USD MILLION) 195
TABLE 114 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION,
2026–2031 (USD MILLION) 195
TABLE 115 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 196
TABLE 116 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 196
TABLE 117 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (TONS) 196
TABLE 118 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (TONS) 197
TABLE 119 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 197
TABLE 120 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 197
TABLE 121 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2022–2025 (USD MILLION) 198
TABLE 122 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026–2031 (USD MILLION) 198
TABLE 123 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2022–2025 (USD MILLION) 198
TABLE 124 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2026–2031 (USD MILLION) 198
TABLE 125 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 199
TABLE 126 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 200
TABLE 127 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 200
TABLE 128 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 200
TABLE 129 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 201
TABLE 130 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 201
TABLE 131 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 202
TABLE 132 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 202
TABLE 133 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 203
TABLE 134 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 203
TABLE 135 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 203
TABLE 136 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 204
TABLE 137 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 204
TABLE 138 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 205
TABLE 139 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 205
TABLE 140 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 205
TABLE 141 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 206
TABLE 142 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 206
TABLE 143 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 207
TABLE 144 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 207
TABLE 145 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 208
TABLE 146 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 208
TABLE 147 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 208
TABLE 148 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 209
TABLE 149 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 210
TABLE 150 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 211
TABLE 151 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022–2025 (USD MILLION) 211
TABLE 152 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026–2031 (USD MILLION) 211
TABLE 153 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 212
TABLE 154 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 212
TABLE 155 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (TONS) 212
TABLE 156 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (TONS) 213
TABLE 157 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 213
TABLE 158 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 213
TABLE 159 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2022–2025 (USD MILLION) 214
TABLE 160 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026–2031 (USD MILLION) 214
TABLE 161 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2022–2025 (USD MILLION) 214
TABLE 162 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2026–2031 (USD MILLION) 214
TABLE 163 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 215
TABLE 164 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 216
TABLE 165 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 216
TABLE 166 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 216
TABLE 167 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 217
TABLE 168 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 218
TABLE 169 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 218
TABLE 170 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 218
TABLE 171 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 219
TABLE 172 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 220
TABLE 173 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 220
TABLE 174 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 220
TABLE 175 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 221
TABLE 176 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 222
TABLE 177 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 222
TABLE 178 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 222
TABLE 179 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 223
TABLE 180 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 223
TABLE 181 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 224
TABLE 182 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 224
TABLE 183 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 225
TABLE 184 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 225
TABLE 185 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 225
TABLE 186 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 226
TABLE 187 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2022–2025 (USD MILLION) 227
TABLE 188 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 227
TABLE 189 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022–2025 (USD MILLION) 227
TABLE 190 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026–2031 (USD MILLION) 228
TABLE 191 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 228
TABLE 192 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 228
TABLE 193 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (TONS) 229
TABLE 194 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (TONS) 229
TABLE 195 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 229
TABLE 196 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 230
TABLE 197 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2022–2025 (USD MILLION) 230
TABLE 198 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026–2031 (USD MILLION) 230
TABLE 199 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2022–2025 (USD MILLION) 231
TABLE 200 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2026–2031 (USD MILLION) 231
TABLE 201 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 232
TABLE 202 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 232
TABLE 203 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 233
TABLE 204 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 233
TABLE 205 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 234
TABLE 206 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 234
TABLE 207 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 235
TABLE 208 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 235
TABLE 209 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 236
TABLE 210 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 236
TABLE 211 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 236
TABLE 212 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 237
TABLE 213 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2022–2025 (USD MILLION) 237
TABLE 214 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION,
2026–2031 (USD MILLION) 238
TABLE 215 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022–2025 (USD MILLION) 238
TABLE 216 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026–2031 (USD MILLION) 238
TABLE 217 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022–2025 (USD MILLION) 239
TABLE 218 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026–2031 (USD MILLION) 239
TABLE 219 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (TONS) 239
TABLE 220 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (TONS) 240
TABLE 221 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 240
TABLE 222 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 240
TABLE 223 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2022–2025 (USD MILLION) 241
TABLE 224 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026–2031 (USD MILLION) 241
TABLE 225 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022–2025 (USD MILLION) 241
TABLE 226 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026–2031 (USD MILLION) 241
TABLE 227 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 242
TABLE 228 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 243
TABLE 229 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022–2025 (USD MILLION) 243
TABLE 230 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026–2031 (USD MILLION) 243
TABLE 231 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2022–2025 (USD MILLION) 244
TABLE 232 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026–2031 (USD MILLION) 245
TABLE 233 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2022–2025 (USD MILLION) 245
TABLE 234 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026–2031 (USD MILLION) 245
TABLE 235 OVERVIEW OF STRATEGIES ADOPTED BY KEY PROBIOTIC SUPPLEMENTS VENDORS, 2020–2026 246
TABLE 236 PROBIOTIC SUPPLEMENTS MARKET: DEGREE OF COMPETITION 251
TABLE 237 PROBIOTIC SUPPLEMENTS MARKET: REGION FOOTPRINT 258
TABLE 238 PROBIOTIC SUPPLEMENTS MARKET: HEALTH APPLICATION FOOTPRINT 259
TABLE 239 PROBIOTIC SUPPLEMENTS S MARKET: PRODUCT FORM FOOTPRINT 260
TABLE 240 PROBIOTIC SUPPLEMENTS S MARKET: END USER FOOTPRINT 261
TABLE 241 PROBIOTIC SUPPLEMENTS MARKET: DETAILED LIST OF
KEY STARTUPS/SMES, 2025 264
TABLE 242 PROBIOTIC SUPPLEMENTS MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 265
TABLE 243 PROBIOTIC SUPPLEMENTS MARKET: PRODUCT LAUNCHES, 2020–MAY 2026 267
TABLE 244 PROBIOTIC SUPPLEMENTS MARKET: DEALS, 2020–MAY 2026 269
TABLE 245 PROBIOTIC SUPPLEMENTS MARKET: EXPANSIONS, JANUARY 2022–APRIL 2026 271
TABLE 246 NESTLÉ S.A.: COMPANY OVERVIEW 272
TABLE 247 NESTLÉ S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 273
TABLE 248 NESTLÉ S.A.: DEALS 274
TABLE 249 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW 276
TABLE 250 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 277
TABLE 251 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES 278
TABLE 252 YAKULT HONSHA CO., LTD.: DEALS 278
TABLE 253 BIOGAIA: COMPANY OVERVIEW 280
TABLE 254 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 255 BIOGAIA: PRODUCT LAUNCHES 282
TABLE 256 BIOGAIA: DEALS 282
TABLE 257 KERRY GROUP PLC: COMPANY OVERVIEW 284
TABLE 258 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
TABLE 259 KERRY GROUP PLC: DEALS 286
TABLE 260 AMWAY: COMPANY OVERVIEW 287
TABLE 261 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 288
TABLE 262 AMWAY: PRODUCT LAUNCHES 289
TABLE 263 NATURE’S WAY: COMPANY OVERVIEW 290
TABLE 264 NATURE’S WAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 291
TABLE 265 NATURE’S WAY: EXPANSIONS 292
TABLE 266 HERBALIFE LTD.: COMPANY OVERVIEW 293
TABLE 267 HERBALIFE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294
TABLE 268 HERBALIFE LTD.: DEALS 295
TABLE 269 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW 296
TABLE 270 MORINAGA MILK INDUSTRY CO., LTD.:
PRODUCTS/SOLUTIONS/SERVICES OFFERED 297
TABLE 271 MORINAGA MILK INDUSTRY CO., LTD.: DEALS 298
TABLE 272 JARROW FORMULAS, INC.: COMPANY OVERVIEW 299
TABLE 273 JARROW FORMULAS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300
TABLE 274 JARROW FORMULAS, INC.: PRODUCT LAUNCHES 300
TABLE 275 JARROW FORMULAS, INC.: DEALS 301
TABLE 276 SYMRISE AG: COMPANY OVERVIEW 302
TABLE 277 SYMRISE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 303
TABLE 278 SYMRISE AG: PRODUCT LAUNCHES 304
TABLE 279 METAGENICS, INC.: BUSINESS OVERVIEW 305
TABLE 280 METAGENICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 305
TABLE 281 METAGENICS, INC.: DEALS 306
TABLE 282 OPTIBIOTIX HEALTH PLC: COMPANY OVERVIEW 307
TABLE 283 OPTIBIOTIX HEALTH PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 308
TABLE 284 OPTIBAC PROBIOTICS LTD.: COMPANY OVERVIEW 310
TABLE 285 OPTIBAC PROBIOTICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 311
TABLE 286 OPTIBAC PROBIOTICS LTD.: PRODUCT LAUNCHES 312
TABLE 287 AB-BIOTICS S.A.: COMPANY OVERVIEW 313
TABLE 288 AB-BIOTICS S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 314
TABLE 289 AB-BIOTICS S.A.: DEALS 314
TABLE 290 LIFEWAY FOODS, INC.: COMPANY OVERVIEW 316
TABLE 291 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 317
TABLE 292 SEED HEALTH, INC.: COMPANY OVERVIEW 319
TABLE 293 SEED HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 319
TABLE 294 SEED HEALTH, INC.: PRODUCT LAUNCHES 320
TABLE 295 PENDULUM THERAPEUTICS: COMPANY OVERVIEW 321
TABLE 296 PENDULUM THERAPEUTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 321
TABLE 297 PENDULUM THERAPEUTICS: PRODUCT LAUNCHES 322
TABLE 298 PENDULUM THERAPEUTICS: DEALS 322
TABLE 299 FLORE INC.: COMPANY OVERVIEW 323
TABLE 300 FLORE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 323
TABLE 301 CUSTOM PROBIOTICS INC.: COMPANY OVERVIEW 325
TABLE 302 CUSTOM PROBIOTICS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 325
TABLE 303 ORA ORGANIC: COMPANY OVERVIEW 327
TABLE 304 ORA ORGANIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 328
TABLE 305 LOVEBUG PROBIOTICS: BUSINESS OVERVIEW 329
TABLE 306 BIOHM HEALTH: BUSINESS OVERVIEW 330
TABLE 307 TONIIQ: BUSINESS OVERVIEW 331
TABLE 308 FITBIOMICS: BUSINESS OVERVIEW 332
TABLE 309 RESBIOTIC NUTRITION: BUSINESS OVERVIEW 332
TABLE 310 ADJACENT MARKETS TO PROBIOTIC SUPPLEMENTS MARKET 344
TABLE 311 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 345
TABLE 312 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 346
TABLE 313 PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 347
TABLE 314 PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 347
FIGURE 1 MARKET SCENARIO 39
FIGURE 2 PROBIOTIC SUPPLEMENTS MARKET, 2022–2031 40
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET, 2020–JANUARY 2026 40
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROBIOTIC SUPPLEMENTS MARKET 41
FIGURE 5 HIGH-GROWTH SEGMENTS IN PROBIOTIC SUPPLEMENTS MARKET, 2026–2031 42
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 43
FIGURE 7 RISING CONSUMER FOCUS ON GUT HEALTH, IMMUNITY, AND PREVENTIVE HEALTHCARE TO DRIVE MARKET 45
FIGURE 8 CAPSULES SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 46
FIGURE 9 BACTERIA SEGMENT TO DOMINATE MARKET IN 2026 46
FIGURE 10 E-COMMERCE SEGMENT TO LEAD MARKET IN 2026 47
FIGURE 11 ADULTS SEGMENT TO DOMINATE MARKET IN 2026 47
FIGURE 12 DIGESTIVE & GUT HEALTH SEGMENT TO DOMINATE MARKET IN 2026 48
FIGURE 13 US TO LEAD MARKET IN 2026 48
FIGURE 14 PROBIOTIC SUPPLEMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 15 PROBIOTIC SUPPLEMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 62
FIGURE 16 WORLD POPULATION, BY ECONOMY, 1950–2050 65
FIGURE 17 POPULATION GROWTH TREND, 1950–2050 66
FIGURE 18 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 19 PROBIOTIC SUPPLEMENTS MARKET: ECOSYSTEM ANALYSIS 69
FIGURE 20 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS OFFERED
BY KEY PLAYERS, BY PRODUCT FORM, 2025 (USD/KG) 71
FIGURE 21 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS, BY REGION,
2021–2025 (USD/KG) 71
FIGURE 22 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 75
FIGURE 23 INVESTMENT AND FUNDING SCENARIO, 2025 75
FIGURE 24 PATENTS APPLIED AND GRANTED, MAY 2016–MAY 2026 83
FIGURE 25 FUTURE APPLICATIONS 85
FIGURE 26 PROBIOTIC SUPPLEMENTS MARKET DECISION-MAKING FACTORS 129
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT 130
FIGURE 28 KEY BUYING CRITERIA, BY PRODUCT FORMAT 131
FIGURE 29 ADOPTION BARRIERS AND INTERNAL CHALLENGES 133
FIGURE 30 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM,
2026 VS. 2031 (USD MILLION) 138
FIGURE 31 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL,
2026 VS. 2031 (USD MILLION) 148
FIGURE 32 PROBIOTIC SUPPLEMENTS MARKET, BY END USER,
2026 VS. 2031 (USD MILLION) 156
FIGURE 33 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION,
2026 VS. 2031 (USD MILLION) 163
FIGURE 34 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT,
2026 VS. 2031 (USD MILLION) 173
FIGURE 35 PROBIOTIC SUPPLEMENTS MARKET GROWTH, BY KEY COUNTRY, 2026–2031 181
FIGURE 36 EUROPE: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT 194
FIGURE 37 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT 210
FIGURE 38 PROBIOTIC SUPPLEMENTS MARKET: REVENUE ANALYSIS,
2023–2025 (USD BILLION) 249
FIGURE 39 SHARE ANALYSIS OF LEADING COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET, 2025 250
FIGURE 40 COMPARATIVE ANALYSIS OF VENDOR BRANDS 253
FIGURE 41 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 256
FIGURE 42 PROBIOTIC SUPPLEMENTS MARKET: COMPANY FOOTPRINT 257
FIGURE 43 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 263
FIGURE 44 COMPANY VALUATION OF KEY PROBIOTIC SUPPLEMENTS VENDORS 266
FIGURE 45 EV/EBITDA OF KEY COMPANIES 266
FIGURE 46 NESTLÉ S.A.: COMPANY SNAPSHOT 273
FIGURE 47 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT 277
FIGURE 48 BIOGAIA: COMPANY SNAPSHOT 281
FIGURE 49 KERRY GROUP PLC: COMPANY SNAPSHOT 285
FIGURE 50 AMWAY: COMPANY SNAPSHOT 288
FIGURE 51 HERBALIFE LTD.: COMPANY SNAPSHOT 294
FIGURE 52 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT 297
FIGURE 53 SYMRISE AG: COMPANY SNAPSHOT 303
FIGURE 54 OPTIBIOTIX HEALTH PLC: COMPANY SNAPSHOT 308
FIGURE 55 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT 317
FIGURE 56 PROBIOTIC SUPPLEMENTS MARKET: RESEARCH DESIGN 333
FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 336
FIGURE 58 KEY INSIGHTS FROM INDUSTRY EXPERTS 336
FIGURE 59 BOTTOM-UP APPROACH (BASED ON DISTRIBUTION CHANNEL, BY REGION) 338
FIGURE 60 TOP-DOWN APPROACH - FROM PARENT MARKET 339
FIGURE 61 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY SIDE ANALYSIS 340
FIGURE 62 DATA TRIANGULATION: SUPPLY SIDE 340
FIGURE 63 DATA TRIANGULATION METHODOLOGY 341